clomipramine/olanzapine

1
Reactions 1161 - 21 Jul 2007 Clomipramine/olanzapine Photosensitivity (first report with olanzapine), DRESS and drug hypersensitivity: 2 case reports Two patients developed drug-induced hypersensitivity (DIHS) and drug rash with eosinophilia and systemic symptoms (DRESS) with photodistributed eruptions during treatment with olanzapine (patient 1) or clomipramine (patient 2). Patient 1, a 68-year-old man with schizophrenia, received olanzapine [Zyprexa; dosage not stated] and, 3 months later, he presented with oedematous erythema on his face, lymphadenopathy and fever. On admission, laboratory investigations revealed atypical lymphocytosis (36%), eosinophilia (26%), liver dysfunction (ALT 280 IU/L; AST 320 IU/L) and decreased serum immunoglobulin levels (IgG 760 mg/dL; IgA 64 mg/dL). More than 2 weeks after onset, he had an increase in anti-cytomegalovirus IgG titre. Patch and photopatch testing results suggested DIHS/DRESS with photosensitive eruption. [Patient outcome not stated.] Patient 2, a 33-year-old woman with depression, received clomipramine [Anafranil; dosage and duration of treatment not stated] and developed a photodistributed eruption, generalised lymphadenopathy, hypogammaglobulinaemia (IgG 793 mg/dL; IgA 64 mg/dL), eosinophilia (30%) and atypical lymphocytes (25%) followed by liver dysfunction [time to reaction onset not stated]. More than 2 weeks after onset, she had an increased in anti-human herpes virus-6 IgG titres. She was diagnosed with DIHS/DRESS with a photodistributed eruption. [Patient outcome not stated.] Author comment: "[I]t is possible that photoirradiation and hypogammaglobulinemia in the early stage of DIHS/ DRESS play a role in the progression to an immunodeficient environment in photoexposed skin areas in which viral reactivation occurs and initiates the development of DIHS/ DRESS." Nishimura Y. Photosensitivity might be associated with drug-induced hypersensitivity syndrome. Dermatology 214: 338-339, No. 4, 2007 - Japan 801078908 » Editorial comment: A search of AdisBase and Medline did not reveal any previous case reports of photosensitivity associated with olanzapine. The WHO Adverse Drug Reactions database contained 32 reports of photosensitivity reaction associated with olanzapine. 1 Reactions 21 Jul 2007 No. 1161 0114-9954/10/1161-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: phamdang

Post on 16-Mar-2017

213 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Clomipramine/olanzapine

Reactions 1161 - 21 Jul 2007

★Clomipramine/olanzapine

Photosensitivity (first report with olanzapine),DRESS and drug hypersensitivity: 2 case reports

Two patients developed drug-induced hypersensitivity(DIHS) and drug rash with eosinophilia and systemicsymptoms (DRESS) with photodistributed eruptions duringtreatment with olanzapine (patient 1) or clomipramine(patient 2).

Patient 1, a 68-year-old man with schizophrenia, receivedolanzapine [Zyprexa; dosage not stated] and, 3 months later,he presented with oedematous erythema on his face,lymphadenopathy and fever. On admission, laboratoryinvestigations revealed atypical lymphocytosis (36%),eosinophilia (26%), liver dysfunction (ALT 280 IU/L; AST320 IU/L) and decreased serum immunoglobulin levels (IgG760 mg/dL; IgA 64 mg/dL). More than 2 weeks after onset, hehad an increase in anti-cytomegalovirus IgG titre. Patch andphotopatch testing results suggested DIHS/DRESS withphotosensitive eruption. [Patient outcome not stated.]

Patient 2, a 33-year-old woman with depression, receivedclomipramine [Anafranil; dosage and duration of treatment notstated] and developed a photodistributed eruption,generalised lymphadenopathy, hypogammaglobulinaemia(IgG 793 mg/dL; IgA 64 mg/dL), eosinophilia (30%) andatypical lymphocytes (25%) followed by liver dysfunction[time to reaction onset not stated]. More than 2 weeks afteronset, she had an increased in anti-human herpes virus-6 IgGtitres. She was diagnosed with DIHS/DRESS with aphotodistributed eruption. [Patient outcome not stated.]

Author comment: "[I]t is possible that photoirradiationand hypogammaglobulinemia in the early stage of DIHS/DRESS play a role in the progression to an immunodeficientenvironment in photoexposed skin areas in which viralreactivation occurs and initiates the development of DIHS/DRESS."Nishimura Y. Photosensitivity might be associated with drug-inducedhypersensitivity syndrome. Dermatology 214: 338-339, No. 4, 2007 -Japan 801078908

» Editorial comment: A search of AdisBase and Medline didnot reveal any previous case reports of photosensitivityassociated with olanzapine. The WHO Adverse Drug Reactionsdatabase contained 32 reports of photosensitivity reactionassociated with olanzapine.

1

Reactions 21 Jul 2007 No. 11610114-9954/10/1161-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved